|
Volumn 35, Issue 5, 2000, Pages 487-497
|
Growth hormone secretagogues derived from NN703 with hydrazides as C- terminal
|
Author keywords
GHRP; Growth hormone releasing peptides; Growth hormone secretagogue; Half life; Hydrazides; MK677; NN703; Volume of distribution
|
Indexed keywords
3 AMINO 3 METHYL N [2,3,4,5 TETRAHYDRO 2 OXO 1 [[2' (1H TETRAZOL 5 YL) 1,1' BIPHENYL 4 YL]METHYL] 1H 1 BENZAZEPIN 3 YL]BUTANAMIDE;
GROWTH HORMONE RELEASING FACTOR DERIVATIVE;
HEXARELIN;
HYDRAZIDE DERIVATIVE;
IBUTAMOREN;
IPAMORELIN;
PRALMORELIN;
TABIMORELIN;
UNCLASSIFIED DRUG;
ALKYLATION;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ARTICLE;
CARBOXY TERMINAL SEQUENCE;
CHEMICAL MODIFICATION;
CONTROLLED STUDY;
DERIVATIZATION;
DISTRIBUTION VOLUME;
DOG;
DRUG BIOAVAILABILITY;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG POTENCY;
DRUG SCREENING;
DRUG SYNTHESIS;
FEMALE;
GROWTH HORMONE RELEASE;
HYPOPHYSIS CELL;
LIPOPHILICITY;
MALE;
NONHUMAN;
RAT;
|
EID: 0344002677
PISSN: 02235234
EISSN: None
Source Type: Journal
DOI: 10.1016/S0223-5234(00)00146-X Document Type: Article |
Times cited : (21)
|
References (23)
|